Tellgen Corp Class A 300642
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥14.86
- Day Range
- ¥15.28–17.68
- 52-Week Range
- ¥9.94–19.68
- Bid/Ask
- ¥16.19 / ¥16.21
- Market Cap
- ¥2.64 Bil
- Volume/Avg
- 10.7 Mil / 4.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 59.27
- Price/Sales
- 5.01
- Dividend Yield (Trailing)
- 1.01%
- Dividend Yield (Forward)
- 1.01%
- Total Yield
- 1.01%
Company Profile
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 574
- Website
- http://www.tellgen.com
Comparables
Valuation
|
Metric
|
300642
|
EXAS
|
300685
|
|---|---|---|---|
Price/Earnings (Normalized) | 59.27 | 733.25 | 33.32 |
Price/Book Value | 1.63 | 4.01 | 5.42 |
Price/Sales | 5.01 | 4.83 | 8.47 |
Price/Cash Flow | 16.41 | 64.53 | 26.09 |
Price/Earnings
300642
EXAS
300685
Financial Strength
|
Metric
|
300642
|
EXAS
|
300685
|
|---|---|---|---|
Quick Ratio | 6.08 | 1.81 | 7.70 |
Current Ratio | 7.48 | 2.17 | 7.98 |
Interest Coverage | 101.44 | −7.23 | 272.48 |
Quick Ratio
300642
EXAS
300685
Profitability
|
Metric
|
300642
|
EXAS
|
300685
|
|---|---|---|---|
Return on Assets (Normalized) | 2.44% | 0.13% | 13.93% |
Return on Equity (Normalized) | 2.73% | 0.26% | 15.61% |
Return on Invested Capital (Normalized) | 2.41% | 0.43% | 13.94% |
Return on Assets
300642
EXAS
300685
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Xnpvywp | Pcbbd | $197.2 Bil | |||
| Stryker Corp
SYK
| Njcbztbbsx | Bvph | $131.5 Bil | |||
| Boston Scientific Corp
BSX
| Rhnkfvdt | Ywmscn | $124.3 Bil | |||
| Medtronic PLC
MDT
| Sznnkrcs | Cjgmpl | $111.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Kvyghgjhd | Jxdnbp | $38.9 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Phpcb | Rycn | $30.2 Bil | |||
| DexCom Inc
DXCM
| Srrbzpjfz | Xfz | $27.5 Bil | |||
| Steris PLC
STE
| Ykvqvmywq | Sqmnkx | $22.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Tcjphqtkmd | Gflr | $20.8 Bil | |||
| Insulet Corp
PODD
| Vrkvyshyd | Bkvsyzs | $16.0 Bil |
United States